Pan Cancer T

Pan Cancer T secures €4.25m in Seed Extension Round to advance next-generation T cell therapies

July 11 2024, Rotterdam, the Netherlands – Pan Cancer T B.V., a pioneering biotech start-up developing next-generation T cell therapies for solid cancer treatment, has successfully closed a €4.25m Seed Extension round. This round includes a new investor InnovationQuarter and continued support from existing investors: Van Herk Ventures, Thuja Capital, Swanbridge Capital and Erasmus MC...
Marconistraat 16 3029 AK, Rotterdam The Netherlands